Kanfit Awarded European Commission’s Competitive Horizon 2020 Research Grant
Kanfit Ltd. is a partner in the HYPERDIAMOND project, a consortium of internationally renowned research institutes and innovative SMEs. The project works to develop and commercialize two platforms for hyperpolarized, MRI-based molecular imaging to address the diagnostic needs in oncology, cardiology and neurology. The four year project is being funded by the EU.
Utilizing the unique quantum properties of nitrogen-vacancy (N-V) centers in diamonds, the goal is to present a generic breakthrough technology for enabling previously unachievable, highly sensitive quantification of metabolic perturbations and targeted imaging. The result: earlier diagnostic and personalized therapies, substantially improving patient management of cancer, life-science and medical research, as well as drug discovery and development. For example, by tailoring cancer treatment strategy via the metabolic information provided by hyperpolarized metabolites, the following can be achieved:
- Faster decision making about ineffective treatment
- Better assessment and tailoring of effective treatments
- Improved endpoint of the treatment and reduce rate of recurring cancer
Kanfit’s role in the consortium is to design and manufacture two types of permanent magnets and execute the integration of the entire system. Working in cooperation with Lapuntuh Magnetics, the two companies will develop a novel permanent-magnet for hyperpolarizers which will dramatically improve the performance of the Diamond Hyperpolarizer. This new device will enable Kanfit to continue growing its medical devices subdivision, and will provide an avenue for Lapuntuh Magnetics to enlarge its market of permanent-magnet based imaging and diagnostics systems.
The HYPERDIAMOND consortium is composed of a multidisciplinary team of experts in the field of molecular imaging, NMR expertise, nanodiamond material science, theoretical and experimental quantum physics, diamond surface bio-chemistry, small animal MR imaging, pre-clinical expertise, medical devices and magnetics production. In addition to Kanfit, consortium members include:
This project has received funding from the European Union’s Horizon 2020 research and innovation programme 2014-2018 under grant agreement No 667192.
- Ulm University
- The Hebrew University of Jerusalem
- NVision Medical Imaging
- Université François Rabelais of Tours
- Research Fund of the Hadassah Medical Organization
- Karlsruhe Institute of Technology
- Austrian Institute of Technology
- L.M. Van Moppes Sons SA